Cross-cutting research makes promising strides toward clinical testing
New research shows diabetes drug could provide brain protection to children who get radiation for brain tumours
Thanks to funding from Medicine by Design, a University of Toronto scientist and her team are closer to finding a way to protect the brain from damage for children who must be treated with cranial radiation.
Medicine by Design's $4-million Pivotal Experiment Fund aims to bridge one of the critical gaps in the “valley of death” between a research discovery and a translatable therapy.
Medicine by Design is launching a new discussion group series to provide an opportunity for investigators [...]
An interdisciplinary team of scientists, funded by Medicine by Design, aims to use retinal stem cells to restore vision.
Team led by pioneering stem cell scientist is one step closer to the clinic with cell-based therapies for liver disease.
Medicine by Design-funded research team says the new treatment approach is not far from clinical trials. This is one of the ways Medicine by Design is transforming human health.
Medicine by Design-funded researchers develop cell injection technique that could help reverse vision loss
The technique could point the way toward new treatments with the potential to reverse forms of vision loss that are currently incurable.
U of T and SickKids researchers demonstrate drug stimulation of neural stem cell repair leads to promising impact on treatment of childhood brain injury in survivors of brain cancer
Cross-species study shows that Type 2 diabetes drug metformin could change the way childhood brain injury is treated
Medicine by Design-funded team uses stem cells to grow functional blood vessel cells found in the liver
Discovery to provide insights into liver development and disease progression
Medicine by Design is expanding its regenerative medicine research portfolio with the addition of four multi-disciplinary, multi-institution projects. “These team projects build on Medicine by Design’s successes over its first three years and will strengthen the University of Toronto and its affiliated hospitals as a global centre for regenerative medicine,” said Michael Sefton, executive director of Medicine by Design.